Cochrane Abstracts
Co‐formulated abacavir‐lamivudine‐zidovudine for initial treatment of HIV infection and AIDS
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Co‐formulated Abacavir‐lamivudine‐zidovudine for Initial Treatment of HIV Infection and AIDS." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434003/all/Co���formulated_abacavir���lamivudine���zidovudine_for_initial_treatment_of_HIV_infection_and_AIDS. Accessed 02 December 2023.
Co‐formulated abacavir‐lamivudine‐zidovudine for initial treatment of HIV infection and AIDS. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434003/all/Co���formulated_abacavir���lamivudine���zidovudine_for_initial_treatment_of_HIV_infection_and_AIDS. Accessed December 2, 2023.
Co‐formulated abacavir‐lamivudine‐zidovudine for initial treatment of HIV infection and AIDS. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/434003/all/Co���formulated_abacavir���lamivudine���zidovudine_for_initial_treatment_of_HIV_infection_and_AIDS
Co‐formulated Abacavir‐lamivudine‐zidovudine for Initial Treatment of HIV Infection and AIDS [Internet]. In: Cochrane Abstracts. [cited 2023 December 02]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434003/all/Co���formulated_abacavir���lamivudine���zidovudine_for_initial_treatment_of_HIV_infection_and_AIDS.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Co‐formulated abacavir‐lamivudine‐zidovudine for initial treatment of HIV infection and AIDS
ID - 434003
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434003/all/Co���formulated_abacavir���lamivudine���zidovudine_for_initial_treatment_of_HIV_infection_and_AIDS
DB - Evidence Central
DP - Unbound Medicine
ER -
